NCT02277587View on ClinicalTrials.gov

Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Primary Adrenal InsufficiencySecondary Adrenal Insufficiency
Interventions
DRUG

Plenadren

Oral Tablets: 20-25-30 mg

DRUG

Conventional glucocorticoid therapy

Oral Tablets: 20-25-30- 37.5 mg

Trial Locations (1)

00161

Department of Experimental Medicine, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02277587 - Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM) | Biotech Hunter | Biotech Hunter